Teladoc Stock Today
| TDOC Stock | USD 8.62 0.13 1.53% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Teladoc is trading at 8.62 as of the 16th of March 2025, a 1.53 percent increase since the beginning of the trading day. The stock's open price was 8.49. Teladoc has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 1st of July 2015 | Category Healthcare | Classification Health Care |
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company was incorporated in 2002 and is headquartered in Purchase, New York. Teladoc Health operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. The company has 173.67 M outstanding shares of which 25.02 M shares are at this time shorted by private and institutional investors with about 2.22 trading days to cover. More on Teladoc
Moving against Teladoc Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Teladoc Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | CPA III | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Corona Opportunity (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, NYSE Composite, Corona Opportunity, Health Care, Health Care Technology, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsTeladoc can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Teladoc's financial leverage. It provides some insight into what part of Teladoc's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Teladoc (TDOC) is traded on New York Stock Exchange in USA. It is located in 2 Manhattanville Road, Purchase, NY, United States, 10577 and employs 4,620 people. Teladoc is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.5 B. Teladoc conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 173.67 M outstanding shares of which 25.02 M shares are at this time shorted by private and institutional investors with about 2.22 trading days to cover.
Teladoc currently holds about 883.7 M in cash with 293.68 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.47.
Check Teladoc Probability Of Bankruptcy
Ownership AllocationTeladoc shows a total of 173.67 Million outstanding shares. The majority of Teladoc outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Teladoc to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Teladoc. Please pay attention to any change in the institutional holdings of Teladoc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Teladoc Ownership Details
Teladoc Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Two Sigma Advisers, Llc | 2024-12-31 | 2.3 M | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 2.2 M | |
| Two Sigma Investments Llc | 2024-12-31 | 2 M | |
| Nuveen Asset Management, Llc | 2024-12-31 | 1.9 M | |
| Voloridge Investment Management, Llc | 2024-12-31 | 1.8 M | |
| Northern Trust Corp | 2024-12-31 | 1.7 M | |
| Barclays Plc | 2024-12-31 | 1.6 M | |
| Tang Capital Management Llc | 2024-12-31 | 1.4 M | |
| Millennium Management Llc | 2024-12-31 | 1.4 M | |
| Vanguard Group Inc | 2024-12-31 | 18.5 M | |
| Blackrock Inc | 2024-12-31 | 17.1 M |
Teladoc Historical Income Statement
Teladoc Stock Against Markets
Teladoc Corporate Directors
| Sandra Fenwick | Independent Director | Profile | |
| Christopher Bischoff | Independent Director | Profile | |
| David Shedlarz | Independent Director | Profile | |
| William Frist | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.87) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.